On Tuesday, Athira Pharma Inc (NASDAQ: ATHA) opened higher 7.06% from the last session, before settling in for the closing price of $0.55. Price fluctuations for ATHA have ranged from $0.41 to $4.30 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 21.60% at the time writing. With a float of $35.56 million, this company’s outstanding shares have now reached $38.67 million.
In an organization with 67 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 55.98%, operating margin of -7003.5%, and the pretax margin is -6595.53%.
Athira Pharma Inc (ATHA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Athira Pharma Inc is 8.03%, while institutional ownership is 47.77%. The most recent insider transaction that took place on Sep 05 ’24, was worth 1. Before that another transaction happened on Sep 05 ’24, when Company’s CFO and Chief Business Officer sold 1,272 for $0.57, making the entire transaction worth $720. This insider now owns 97,532 shares in total.
Athira Pharma Inc (ATHA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.60% per share during the next fiscal year.
Athira Pharma Inc (NASDAQ: ATHA) Trading Performance Indicators
Check out the current performance indicators for Athira Pharma Inc (ATHA). In the past quarter, the stock posted a quick ratio of 2.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.85, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.51 in one year’s time.
Technical Analysis of Athira Pharma Inc (ATHA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.3 million. That was inferior than the volume of 1.53 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 60.90%. Additionally, its Average True Range was 0.05.
During the past 100 days, Athira Pharma Inc’s (ATHA) raw stochastic average was set at 5.38%, which indicates a significant decrease from 65.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.33% in the past 14 days, which was lower than the 262.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5998, while its 200-day Moving Average is $1.7874. However, in the short run, Athira Pharma Inc’s stock first resistance to watch stands at $0.6057. Second resistance stands at $0.6248. The third major resistance level sits at $0.6539. If the price goes on to break the first support level at $0.5575, it is likely to go to the next support level at $0.5284. The third support level lies at $0.5093 if the price breaches the second support level.
Athira Pharma Inc (NASDAQ: ATHA) Key Stats
There are currently 38,669K shares outstanding in the company with a market cap of 24.29 million. Presently, the company’s annual sales total 0 K according to its annual income of -117,670 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -28,740 K.
